CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes.
Flawless balance sheet with proven track record.
Share Price & News
How has CorVel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CRVL's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CRVL underperformed the US Healthcare industry which returned 13.7% over the past year.
Return vs Market: CRVL underperformed the US Market which returned 12.5% over the past year.
Price Volatility Vs. Market
How volatile is CorVel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StA Rising Share Price Has Us Looking Closely At CorVel Corporation's (NASDAQ:CRVL) P/E Ratio
2 months ago | Simply Wall StWith EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting
2 months ago | Simply Wall StCorVel Corporation (NASDAQ:CRVL) Insiders Have Been Selling
Is CorVel undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CRVL ($79.49) is trading above our estimate of fair value ($67.5)
Significantly Below Fair Value: CRVL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CRVL is poor value based on its PE Ratio (30.7x) compared to the US Healthcare industry average (27.7x).
PE vs Market: CRVL is poor value based on its PE Ratio (30.7x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRVL is overvalued based on its PB Ratio (7.5x) compared to the US Healthcare industry average (3x).
How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CorVel has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out CorVel's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Explore growth companies in the Healthcare industry.
How has CorVel performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRVL has high quality earnings.
Growing Profit Margin: CRVL's current net profit margins (8%) are higher than last year (7.8%).
Past Earnings Growth Analysis
Earnings Trend: CRVL's earnings have grown by 14.2% per year over the past 5 years.
Accelerating Growth: CRVL's earnings growth over the past year (1.4%) is below its 5-year average (14.2% per year).
Earnings vs Industry: CRVL earnings growth over the past year (1.4%) underperformed the Healthcare industry 16.6%.
Return on Equity
High ROE: CRVL's Return on Equity (25%) is considered high.
How is CorVel's financial position?
Financial Position Analysis
Short Term Liabilities: CRVL's short term assets ($209.0M) exceed its short term liabilities ($133.7M).
Long Term Liabilities: CRVL's short term assets ($209.0M) exceed its long term liabilities ($92.9M).
Debt to Equity History and Analysis
Debt Level: CRVL is debt free.
Reducing Debt: CRVL has not had any debt for past 5 years.
Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.
What is CorVel current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CRVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Michael Combs (56 yo)
Mr. Michael G. Combs has been as the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp ...
CEO Compensation Analysis
Compensation vs Market: Michael's total compensation ($USD1.43M) is below average for companies of similar size in the US market ($USD4.67M).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
|Chairman & COO||29.33yrs||US$401.71k||9.14% |
|President & CEO||1.58yrs||US$1.43m||0.021% |
|Chief Financial Officer||1.83yrs||US$512.62k||0.0051% |
|Vice President of Accounting||6.17yrs||US$275.14k||0.00096% |
|Chief Information Officer||3.33yrs||US$596.59k||no data|
|Chief Marketing Officer||3.75yrs||US$625.10k||0.028% |
|Investor Relation||no data||no data||no data|
|Vice President of Legal & Human Resources||4.33yrs||no data||no data|
Experienced Management: CRVL's management team is considered experienced (4 years average tenure).
|Chairman & COO||29.33yrs||US$401.71k||9.14% |
|Independent Director||29.25yrs||US$91.70k||0.74% |
|Independent Director||29.92yrs||US$87.70k||1.14% |
|Lead Independent Director||no data||US$99.70k||0.34% |
|Independent Director||17.25yrs||US$91.70k||0.28% |
|Independent Director||12.5yrs||US$88.70k||0.067% |
Experienced Board: CRVL's board of directors are seasoned and experienced ( 29.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CRVL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CorVel Corporation's company bio, employee growth, exchange listings and data sources
- Name: CorVel Corporation
- Ticker: CRVL
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.431b
- Shares outstanding: 18.01m
- Website: https://www.corvel.com
Number of Employees
- CorVel Corporation
- 1920 Main Street
- Suite 900
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CRVL||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jun 1991|
CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. I ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/03 00:31|
|End of Day Share Price||2020/07/31 00:00|